重症筋無力症(Myasthenia Gravis)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Myasthenia Gravis - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Myasthenia Gravis Overview 8
Therapeutics Development 9
Pipeline Products for Myasthenia Gravis – Overview 9
Pipeline Products for Myasthenia Gravis – Comparative Analysis 10
Myasthenia Gravis – Therapeutics under Development by Companies 11
Myasthenia Gravis – Therapeutics under Investigation by Universities/Institutes 13
Myasthenia Gravis – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Myasthenia Gravis – Products under Development by Companies 17
Myasthenia Gravis – Products under Investigation by Universities/Institutes 18
Myasthenia Gravis – Companies Involved in Therapeutics Development 19
Alexion Pharmaceuticals, Inc. 19
Alnylam Pharmaceuticals, Inc. 20
Astellas Pharma Inc. 21
Biokine Therapeutics Ltd. 22
CuraVac, Inc. 23
Cytokinetics, Inc. 24
GlaxoSmithKline plc 25
Grifols, S.A. 26
HanAll Biopharma Co., Ltd. 27
Neurotune AG 28
Pfizer Inc. 29
Regenesance BV 30
Toleranzia AB 31
Myasthenia Gravis – Therapeutics Assessment 32
Assessment by Monotherapy Products 32
Assessment by Target 33
Assessment by Mechanism of Action 35
Assessment by Route of Administration 37
Assessment by Molecule Type 39
Drug Profiles 41
ALN-CC5 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
belimumab – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
BKT-130 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
CK-2066260 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
eculizumab – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
GL-2045 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
HL-161 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
immune globulin (human) – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
NT-1654 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Recombinant Protein for Myasthenia Gravis – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Recombinant Protein to Antagonize LTB4 and C5 for Respiratory, Immunological, CNS and Hematological Disorders – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Regenemab – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
tacrolimus – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
tirasemtiv – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
Vaccine for Myasthenia Gravis – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Vaccine for Myasthenia Gravis – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Myasthenia Gravis – Recent Pipeline Updates 69
Myasthenia Gravis – Dormant Projects 85
Myasthenia Gravis – Discontinued Products 86
Myasthenia Gravis – Product Development Milestones 87
Featured News & Press Releases 87
Dec 10, 2014: Soliris (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis 87
Sep 16, 2014: Alnylam Presents New Pre-Clinical Data with ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 in Development for the Treatment of Complement-Mediated Diseases 88
Aug 01, 2014: European Commission Grants Orphan Drug Designation to Soliris (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 89
Jun 17, 2014: FDA Grants Orphan Drug Designation to Soliris (eculizumab) for the Treatment of Patients with Myasthenia Gravis 90
Jun 09, 2014: Alnylam Presents New Pre-Clinical Data with Development Candidate for ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 in Development for the Treatment of Complement-Mediated Diseases 90
Apr 24, 2014: Alexion Initiates Multinational Registration Trials of Eculizumab as a Potential Treatment for Patients with Relapsing Neuromyelitis Optica and Refractory Generalized Myasthenia Gravis 92
Apr 24, 2014: Toleranzia supported by VINNOVA 93
Dec 08, 2013: New Alnylam Pre-clinical Results on ALN-CC5, an RNAi Therapeutic Targeting Complement Component C5 for the Treatment of Complement-Mediated Diseases, Demonstrate up to 98% Serum C5 Knockdown and up to 94% Inhibition of Hemolytic Activity in Non-Human Primates 93
Jun 20, 2013: Alnylam Scientists Present Preclinical Data With ALN-CC5 For Treatment Of Complement-mediated Diseases 96
Mar 21, 2013: Cytokinetics Announces Presentation Of Phase IIA Clinical Trial Data Of Tirasemtiv In Patients With Myasthenia Gravis 97
Appendix 99
Methodology 99
Coverage 99
Secondary Research 99
Primary Research 99
Expert Panel Validation 99
Contact Us 100
Disclaimer 100


【レポート販売概要】

■ タイトル:重症筋無力症(Myasthenia Gravis)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Myasthenia Gravis - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6062IDB
■ 調査対象地域:グローバル
  • 世界のmHealth(モバイルヘルス)アプリおよびソリューション市場
    mHealth is a successful integration of mobile technology and healthcare services that entail a revolution in the global healthcare solutions market. The global mHealth market is estimated to be valued at $6.6 billion in 2013 and is expected to reach $20.7 billion by 2018 at a healthy CAGR of 25.5%. The mobile healthcare market is broadly categorized into connected medical device and healthcare app …
  • 世界の主な銅鉱山分析:Analyzing the Major Copper Mines Worldwide
    The global copper industry expanded by over 40% in 2011 and accounted for $90 billion in revenues. The copper industry was greatly affected by a global drop in commodity prices in 2009, which caused a sharp decline in many markets. However, the decline was promptly reversed by increased consumption especially by fast developing countries like China. The mining of copper is generally confined to a …
  • クラウド高性能計算(HPC)の世界市場
    MarketsandMarkets forecast the cloud High Performance Computing (HPC) market size to grow from USD 4.37 Billion in 2015 to USD 10.83 Billion by 2020, at a compound annual growth rate (CAGR) of 19.9% from 2015 to 2020. HPC involves complex and technical computation that generates huge amount of data making it difficult in collaboration and processing. Cloud HPC addresses these issues by offering di …
  • 農業用生物学的製剤の世界市場:バイオ農薬、バイオスティミュラント、バイオ肥料
    About Agricultural Biologicals Agricultural biologicals are crop protection inputs in agricultural practices, which are organic and ecological in nature. They prevent the use of synthetic and chemical fertilizers like biocides, genetic modifications, and other chemical fertilizers, which subsequently helps protect the environment. Biological sources like microbials, plant extracts, minerals, and b …
  • MEMS医療機器の世界市場2015-2022
    According to Stratistics MRC, the Global Micro-Electro-Mechanical Systems (MEMS) Medical Devices market is accounted for $3.12 billion in 2015 and is expected to reach $10.41 billion by 2022 growing at a CAGR of 18.7% during the forecast period. Growing occurrence of infectious and chronic diseases, technology advancements and growing aging population are the key factors fueling the market growth. …
  • 世界のフェイシャルエステ(顔ケア)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Facial Aesthetics market to grow at a CAGR of 9.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Facial Aesthetics market has also been witnessing an increasing popularity of combination therapies. However, the risk of side effects when using facial aesthetics …
  • グローバルにおける空気圧モーターおよびエンジン市場(~2019)
    The industry report Global Pneumatic Power Motor and Engine Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for pneumatic power motors and engines in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for indu …
  • 世界のサーバーOS市場動向(2012-2016)
    TechNavio's analysts forecast the Global Server Operating Systems market to grow at a CAGR of 3.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for faster data transfer. The Global Server Operating Systems market has also been witnessing the growing adoption of cloud computing. However, the increased adoption of virtualization …
  • 圧力計の世界市場
    About Pressure Transmitters A pressure transmitter is an instrumentation and measurement device used to determine and feed the pressure attribute of a medium. It consists of a sensing unit, amplifier, and an output signal generator. It finds it application in control systems in end-user industries to control the flow rate of the medium. It also senses and transmits the flow rate and temperature of …
  • ガスマスクの世界市場2017-2021
    About Gas MasksGas masks constitute a prominent category of respiratory protection equipment. Also known as respiratory protection masks, they protect the wearer from toxic agents and pollutants in the environment. Gas masks include products that cover the nose and mouth area or a wider range of facial areas. Leading types of gas masks that are available in the market include self-contained breath …
  • 世界のポリカーボネートジオール市場2015
    The Global Polycarbonate Diol Industry Report 2015 is a professional and in-depth study on the current state of the Polycarbonate Diol industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Polycarbonate Diol market analysis is provided for the international markets including development trends, competit …
  • OTN(光伝達網)装置の世界市場2016-2020
    About Optical Transport Network Equipment OTN is a set of network elements that are connected using optical fiber links. The network provides data transportation, switching, multiplexing, supervision, management, and monitoring of channels carrying client signals. The network is defined by the ITU's G.709 interface. This interface has made it possible to provide a network-wide framework, adding si …
  • インシデント対応サービスの世界市場予測(~2021):部品別、セキュリティ種類別(ウェブ、アプリ、クラウド、データベース、エンドポイント、ネットワーク)、組織サイズ別、展開モード別、産業別(ITアウトソーシング、銀行、金融サービス、保険、政府、小売、製造業)、地域別
    “The rising security breaches targeting enterprises and increasing sophistication of cyber-attacks are driving the incident response services market”The incident response services market size is estimated to grow from USD 13.09 billion in 2016 to USD 30.29 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 18.3% from 2016 to 2021. The rising security breaches targeted on enterprises, incr …
  • 無人地上センサ(UGS)の世界市場2018-2022
    107 pages, November 2018 About this market The need for small, lightweight, and low power solutions in the military and aerospace industry is boosting the demand for nanotechnology and microelectromechanical systems (MEMS). This have encouraged manufacturers around the world to develop innovative miniaturized electronics. The low-cost sensors are less sophisticated and are mainly used for routine …
  • 無線LANチップセットの世界市場予測(~2022)
    The Wi-Fi chipset market was valued at USD 15.89 Billion in 2016 and is expected to reach USD 19.72 Billion by 2022, at a CAGR of 3.5% between 2017 and 2022. The growing number of public Wi-Fi hotspots, growth in connected devices ownership, rising demand for WiGig technology, and growth of Wi-Fi technology in enterprise and business are the major drivers for the Wi-Fi chipset market. Wi-Fi has be …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。